Tech Company Financing Transactions

Thymmune Funding Round

On 3/1/2023, Thymmune announced $7 million in Seed financing from private investors, NYBC Ventures and Pillar VC.

Transaction Overview

Company Name
Thymmune
Announced On
3/1/2023
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Seed
Investors

private investors (George Church)

private investors (James Fordyce)

private investors (John Maraganore)

private investors (Judy Pagliuca)

private investors (Mark Bamforth)

private investors (Philip Reilly)

NYBC Ventures

Pillar VC

Proceeds Purpose
The company intends to use the funds to advance its lead product THY-100 into preclinical studies in immune system disorders caused by thymic deficiencies (such as children born without a thymus), which result in a lack of functional T cells, develop its thymic cell engineering platform and expand into additional indications across areas of unmet clinical need in immunology.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
c/o LabCentral 700 Main Street North
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
www.thymmune.com
Email Address
[email protected]
Overview
Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease. The company's cutting-edge approach in iPSC-thymic cell manufacturing can generate off-the-shelf cells at scale. The company is developing a pipeline of therapies to treat immunodeficiencies, transplant-related, and autoimmune disorders.
Profile
Thymmune LinkedIn Company Profile
Social Media
Thymmune Company Twitter Account
Company News
Thymmune News
Facebook
Thymmune on Facebook
YouTube
Thymmune on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Stan Wang
  Stan Wang LinkedIn Profile  Stan Wang Twitter Account  Stan Wang News  Stan Wang on Facebook
Chief Scientific Officer
Bing Lim
  Bing Lim LinkedIn Profile  Bing Lim Twitter Account  Bing Lim News  Bing Lim on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/1/2023: Chloris Geospatial venture capital transaction
Next: 3/1/2023: Qwak venture capital transaction

 

Share this article

 

Where The Data Comes From

We report on funding rounds that are announced publicly. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.